Ionis Pharmaceuticals Inc (IONS) - Financial and Strategic SWOT Analysis Review

May 2021 | 57 pages | ID: I331316F498EN
GlobalData

Abstracts

Ionis Pharmaceuticals Inc (IONS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Ionis Pharmaceuticals Inc (Ionis) formerly ISIS Pharmaceuticals, Inc. focuses on the discovery and development of RNA-targeted drugs. The company develops medicines to treat various diseases including cancer, cardiovascular diseases, pulomonary, neurological and infectious diseases. Its major products include Spinraza for spinal muscular atrophy, Tegsedi for neuropathy and Waylivra familial chylomicronemia syndrome. Ionis also has pipeline products in different phases of clinical trials. It develops products based on its proprietary antisense technology. The company partnered with other pharmaceutical companies to develop range of products in different therapeutic areas. Ionis is headquartered in Carlsbad, California, the US.

Ionis Pharmaceuticals Inc Key Recent Developments

May 05,2021: Ionis reports first quarter 2021 financial results and recent business achievements
May 05,2021: Ionis to host 2021 virtual annual meeting of stockholders
Apr 08,2021: Ionis prices private placement of convertible senior notes
Apr 06,2021: Ionis announces proposed private placement of convertible notes
Mar 26,2021: Ionis to present at upcoming investor conferences

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Ionis Pharmaceuticals Inc - Key Facts
Ionis Pharmaceuticals Inc - Key Employees
Ionis Pharmaceuticals Inc - Key Employee Biographies
Ionis Pharmaceuticals Inc - Major Products and Services
Ionis Pharmaceuticals Inc - History
Ionis Pharmaceuticals Inc - Company Statement
Ionis Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Company Overview
Ionis Pharmaceuticals Inc - Business Description
Product Category: Commercial Revenue
Overview
Performance
Product Category: R&D Revenue under Collaborative Agreements
Performance
Product Category: Akcea Therapeutics
Overview
Performance
Product Category: Ionis Core
Overview
Performance
R&D Overview
Ionis Pharmaceuticals Inc - Corporate Strategy
Ionis Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Ionis Pharmaceuticals Inc - Strengths
Ionis Pharmaceuticals Inc - Weaknesses
Ionis Pharmaceuticals Inc - Opportunities
Ionis Pharmaceuticals Inc - Threats
Ionis Pharmaceuticals Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Ionis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Ionis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Ionis Pharmaceuticals Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 05, 2021: Ionis reports first quarter 2021 financial results and recent business achievements
May 05, 2021: Ionis to host 2021 virtual annual meeting of stockholders
Apr 08, 2021: Ionis prices private placement of convertible senior notes
Apr 06, 2021: Ionis announces proposed private placement of convertible notes
Mar 26, 2021: Ionis to present at upcoming investor conferences
Mar 01, 2021: Ionis establishes new grant program to advance research and understanding of transthyretin amyloidosis
Feb 24, 2021: Ionis reports fourth quarter and full year 2020 financial results and recent business achievements
Feb 11, 2021: Ionis to hold 2020 financial results webcast
Jan 07, 2021: Ionis appoints Eugene Schneider, M.D., as executive vice president and chief clinical development officer
Dec 17, 2020: Stanley T. Crooke, Ph.D., M.D, to retire from Ionis to focus on his scientific interests and n-Lorem Foundation

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Ionis Pharmaceuticals Inc, Key Facts
Ionis Pharmaceuticals Inc, Key Employees
Ionis Pharmaceuticals Inc, Key Employee Biographies
Ionis Pharmaceuticals Inc, Major Products and Services
Ionis Pharmaceuticals Inc, History
Ionis Pharmaceuticals Inc, Subsidiaries
Ionis Pharmaceuticals Inc, Joint Venture
Ionis Pharmaceuticals Inc, Key Competitors
Ionis Pharmaceuticals Inc, Ratios based on current share price
Ionis Pharmaceuticals Inc, Annual Ratios
Ionis Pharmaceuticals Inc, Annual Ratios (Cont...1)
Ionis Pharmaceuticals Inc, Annual Ratios (Cont...2)
Ionis Pharmaceuticals Inc, Interim Ratios
Ionis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Ionis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Ionis Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Ionis Pharmaceuticals Inc, Performance Chart (2016 - 2020)
Ionis Pharmaceuticals Inc, Ratio Charts
Ionis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Ionis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021